Kiotech International Plc, the biotechnology company, has announced in the August update that the interim results to June 2011 are expected to be well ahead of those realised in the interim results of the previous year, and there is every indication that this performance will continue throughout the second half of the year.
The KIO share price has increased by 6.28% over the last year.
This note was prepared by LCF Research Limited using information provided by the subject company’s management or publically available news sources. No representations are made nor warranties given (express or implied) in relation to accuracy and completeness. This document is not an invitation to invest in the subject company and does not purport to contain all the necessary information that a prospective investor might require. LCF Research Limited recommends prospective investors to conduct their own thorough independent analysis of the subject company and the information contained in this note or referred to above.